We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Barr Challenges Savient’s Oxandrin Patents

Law360 (September 27, 2006, 12:00 AM EDT) -- Generic drug maker Barr Laboratories Inc. is going after Savient Pharmaceuticals Inc.’s patents covering its lucrative Oxandrin tablets that promote weight gain.

Barr Laboratories, a subsidiary of Barr Pharmaceuticals Inc., confirmed...
To view the full article, register now.